Shelly Carter

3.1k total citations
25 papers, 2.1k citations indexed

About

Shelly Carter is a scholar working on Hematology, Genetics and Transplantation. According to data from OpenAlex, Shelly Carter has authored 25 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Hematology, 10 papers in Genetics and 7 papers in Transplantation. Recurrent topics in Shelly Carter's work include Hematopoietic Stem Cell Transplantation (16 papers), Renal Transplantation Outcomes and Treatments (7 papers) and Acute Myeloid Leukemia Research (6 papers). Shelly Carter is often cited by papers focused on Hematopoietic Stem Cell Transplantation (16 papers), Renal Transplantation Outcomes and Treatments (7 papers) and Acute Myeloid Leukemia Research (6 papers). Shelly Carter collaborates with scholars based in United States, Canada and Netherlands. Shelly Carter's co-authors include Mary M. Horowitz, Robert J. Soiffer, Vincent T. Ho, Adam Mendizabal, Joanne Kurtzberg, Paul J. Martin, Corey Cutler, Sergio Giralt, Kristin Page and James L.M. Ferrara and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and Blood.

In The Last Decade

Shelly Carter

25 papers receiving 2.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shelly Carter United States 18 1.5k 661 542 433 306 25 2.1k
Pablo Parker United States 25 1.6k 1.1× 645 1.0× 229 0.4× 520 1.2× 297 1.0× 51 2.2k
Hans Hägglund Sweden 24 1.1k 0.7× 482 0.7× 381 0.7× 406 0.9× 180 0.6× 57 1.9k
Carrie L. Kitko United States 24 1.6k 1.1× 802 1.2× 283 0.5× 449 1.0× 142 0.5× 94 2.1k
Roberta King United States 22 2.1k 1.5× 771 1.2× 484 0.9× 470 1.1× 268 0.9× 41 2.7k
Jeanne Palmer United States 30 2.0k 1.4× 559 0.8× 695 1.3× 605 1.4× 217 0.7× 153 2.9k
Juan Wu United States 17 1.1k 0.8× 329 0.5× 171 0.3× 431 1.0× 147 0.5× 52 1.5k
José Carlos Jaime‐Pérez Mexico 25 1.3k 0.9× 365 0.6× 472 0.9× 408 0.9× 55 0.2× 182 2.2k
Alicia Rovó Switzerland 23 966 0.7× 255 0.4× 264 0.5× 401 0.9× 72 0.2× 109 1.7k
Thomas Kiss Canada 19 756 0.5× 264 0.4× 275 0.5× 374 0.9× 80 0.3× 76 1.3k
Betty K. Hamilton United States 20 851 0.6× 244 0.4× 209 0.4× 485 1.1× 77 0.3× 163 1.4k

Countries citing papers authored by Shelly Carter

Since Specialization
Citations

This map shows the geographic impact of Shelly Carter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shelly Carter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shelly Carter more than expected).

Fields of papers citing papers by Shelly Carter

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shelly Carter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shelly Carter. The network helps show where Shelly Carter may publish in the future.

Co-authorship network of co-authors of Shelly Carter

This figure shows the co-authorship network connecting the top 25 collaborators of Shelly Carter. A scholar is included among the top collaborators of Shelly Carter based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shelly Carter. Shelly Carter is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wagner, John E., Mary Eapen, Shelly Carter, et al.. (2014). One-Unit versus Two-Unit Cord-Blood Transplantation for Hematologic Cancers. New England Journal of Medicine. 371(18). 1685–1694. 170 indexed citations
3.
Kamani, Naynesh, Mark C. Walters, Shelly Carter, et al.. (2012). Unrelated Donor Cord Blood Transplantation for Children with Severe Sickle Cell Disease: Results of One Cohort from the Phase II Study from the Blood and Marrow Transplant Clinical Trials Network (BMT CTN). Biology of Blood and Marrow Transplantation. 18(8). 1265–1272. 142 indexed citations
5.
Keever-Taylor, Carolyn A., Steven M. Devine, Robert J. Soiffer, et al.. (2011). Characteristics of CliniMACS® System CD34-Enriched T Cell-Depleted Grafts in a Multicenter Trial for Acute Myeloid Leukemia-Blood and Marrow Transplant Clinical Trials Network (BMT CTN) Protocol 0303. Biology of Blood and Marrow Transplantation. 18(5). 690–697. 49 indexed citations
7.
Page, Kristin, Lijun Zhang, Adam Mendizabal, et al.. (2011). Total Colony-Forming Units Are a Strong, Independent Predictor of Neutrophil and Platelet Engraftment after Unrelated Umbilical Cord Blood Transplantation: A Single-Center Analysis of 435 Cord Blood Transplants. Biology of Blood and Marrow Transplantation. 17(9). 1362–1374. 118 indexed citations
8.
Page, Kristin, Lijun Zhang, Adam Mendizabal, et al.. (2011). The Cord Blood Apgar: a novel scoring system to optimize selection of banked cord blood grafts for transplantation (CME). Transfusion. 52(2). 272–283. 31 indexed citations
11.
Logan, Brent R., Eric Leifer, Christopher Bredeson, et al.. (2008). Use of biological assignment in hematopoietic stem cell transplantation clinical trials. Clinical Trials. 5(6). 607–616. 14 indexed citations
12.
Altmaier, Elizabeth M., et al.. (2007). Social Support, Optimism, and Self-Efficacy Predict Physical and Emotional Well-Being After Bone Marrow Transplantation. Journal of Psychosocial Oncology. 25(1). 87–101. 60 indexed citations
13.
Weisdorf, Daniel J., Shelly Carter, Dennis L. Confer, James L.M. Ferrara, & Mary Horowitz. (2007). Blood and Marrow Transplant Clinical Trials Network (BMT CTN): Addressing Unanswered Questions. Biology of Blood and Marrow Transplantation. 13(3). 257–262. 9 indexed citations
15.
Martin, Paul J., Daniel J. Weisdorf, Donna Przepiorka, et al.. (2006). National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: VI. Design of Clinical Trials Working Group Report. Biology of Blood and Marrow Transplantation. 12(5). 491–505. 122 indexed citations
16.
Cornetta, Kenneth, Mary Laughlin, Shelly Carter, et al.. (2005). Umbilical cord blood transplantation in adults: Results of the prospective cord blood transplantation (COBLT). Biology of Blood and Marrow Transplantation. 11(2). 149–160. 103 indexed citations
17.
Ho, Vincent T., Corey Cutler, Shelly Carter, et al.. (2005). Blood and Marrow Transplant Clinical Trials Network Toxicity Committee Consensus Summary: Thrombotic Microangiopathy after Hematopoietic Stem Cell Transplantation. Biology of Blood and Marrow Transplantation. 11(8). 571–575. 295 indexed citations
18.
Weisdorf, Daniel J., David D. Hurd, Shelly Carter, et al.. (2003). Prospective grading of graft-versus-host disease after unrelated donor marrow transplantation: a grading algorithm versus blinded expert panel review. Biology of Blood and Marrow Transplantation. 9(8). 512–518. 48 indexed citations
19.
Carter, Shelly. (2002). How Much Subjectivity is Needed to Understand Our Lives Objectively?. Qualitative Health Research. 12(9). 1184–1201. 15 indexed citations
20.
Reinsmoen, Nancy L., Arthur J. Matas, Lynn A. Donaldson, & Shelly Carter. (1999). IMPACT OF TRANSFUSIONS AND ACUTE REJECTION ON POSTTRANSPLANTATION DONOR ANTIGEN-SPECIFIC RESPONSES IN TWO STUDY POPULATIONS1,2. Transplantation. 67(5). 697–702. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026